본문으로 건너뛰기
← 뒤로

Yttrium-90 radioembolization therapy prior to liver transplantation for hepatocellular carcinoma improves patient outcomes.

1/5 보강
Hepatobiliary & pancreatic diseases international : HBPD INT 📖 저널 OA 0% 2024: 0/5 OA 2025: 0/25 OA 2026: 0/14 OA 2024~2026 2026 Vol.25(1) p. 4-14
Retraction 확인
출처

Tang R, Wu GD, Li A, Hou YC, Tong X, Lu Q

📝 환자 설명용 한 줄

For early hepatocellular carcinoma (HCC), curative therapies include surgical excision and radiofrequency ablation.

이 논문을 인용하기

↓ .bib ↓ .ris
APA Tang R, Wu GD, et al. (2026). Yttrium-90 radioembolization therapy prior to liver transplantation for hepatocellular carcinoma improves patient outcomes.. Hepatobiliary & pancreatic diseases international : HBPD INT, 25(1), 4-14. https://doi.org/10.1016/j.hbpd.2025.11.003
MLA Tang R, et al.. "Yttrium-90 radioembolization therapy prior to liver transplantation for hepatocellular carcinoma improves patient outcomes.." Hepatobiliary & pancreatic diseases international : HBPD INT, vol. 25, no. 1, 2026, pp. 4-14.
PMID 41330842 ↗

Abstract

For early hepatocellular carcinoma (HCC), curative therapies include surgical excision and radiofrequency ablation. Other treatment modes for advanced HCC involve transarterial chemoembolization. For HCC patients who do not fit the Milan criteria or are waiting for liver transplantation (LT), studies of transarterial radioembolization with Yttrium-90 (Y-90) demonstrated that Y-90 may accomplish a good downstaging or bridging effect before LT and can even achieve complete pathological necrosis. The present review discussed Y-90 radioembolization as a local regional treatment option for advanced and unresectable HCC, with a focus on neoadjuvant intervention before LT.

🏷️ 키워드 / MeSH 📖 같은 키워드 OA만

같은 제1저자의 인용 많은 논문 (5)

🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반